Cargando…
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
BACKGROUND: Patients diagnosed with metastatic breast cancer have poor outcome with a median survival of approximately 2 years. While novel therapeutic options are urgently needed, the great majority of breast cancer research has focused on the primary tumor and less is known about metastatic breast...
Autores principales: | Stenström, Jenny, Hedenfalk, Ingrid, Hagerling, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893927/ https://www.ncbi.nlm.nih.gov/pubmed/33602289 http://dx.doi.org/10.1186/s13058-021-01403-0 |
Ejemplares similares
-
CD169(+) Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, T(regs) and a Worse Prognosis for Patients with Advanced Breast Cancer
por: Briem, Oscar, et al.
Publicado: (2023) -
Roles of the immune system in cancer: from tumor initiation to metastatic progression
por: Gonzalez, Hugo, et al.
Publicado: (2018) -
High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer
por: Rennstam, Karin, et al.
Publicado: (2006) -
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020) -
T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)